Buy Tesamorelin 10mg + woda bakteriostatyczna 3 ml
€80.73
Tesamorelin, 10 mg, with 3 mL bacteriostatic water, is a modified 44-residue peptide for analytical and in vitro GHRH-receptor research. Pharma Research .eu provides documented European supply subject to lot-specific sequence and identity verification.
Buy Tesamorelin, 10 mg + Bacteriostatic Water, 3 mL, for Advanced Laboratory Research in Europe
Tesamorelin is a synthetic, stabilised 44-residue GHRH analogue used as a laboratory reagent in peptide analytics, receptor-signalling research and controlled in vitro investigations. The documented structure contains an N-terminal trans-3-hexenoyl group and a C-terminal amide. Its commonly reported formula is CβββHβββNββOββS, with molecular mass approximately 5,135.8β5,136 Da. Pharma Research .eu presents this 10 mg format with 3 mL bacteriostatic water for qualified European laboratory teams.pubchem.ncbi.nlm.nih+2
Uncompromising Purity and Analytical Characterisation
Tesamorelin should be specified as a modified 44-residue peptide derived from GHRH. The commonly documented sequence is:
trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NHβ
The N-terminal trans-3-hexenoyl group and C-terminal amidation are essential identity features. They distinguish tesamorelin from unmodified GHRH(1β44), shorter fragments and alternative analogues. The sequence should be checked carefully because some commercial records omit residues or present inconsistent forms.genome+1
For laboratory procurement, the suitable target is β₯99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. A credible release package should also include intact-mass confirmation because long peptides can produce truncated, incompletely modified and oxidation-related impurities.
A complete CoA should include:
-
RP-HPLC purity percentage, analytical method and chromatogram.
-
LC-MS, ESI-MS or high-resolution MS identity confirmation.
-
Full 44-residue sequence and stereochemical designation.
-
Confirmation of the trans-3-hexenoyl group and C-terminal amide.
-
Molecular formula and molecular-mass assignment.
-
Free-peptide, acetate or other salt-form information.
-
Visual appearance of the lyophilised material.
-
Residual-solvent results from synthesis and purification.
-
Water or residual-moisture content, where measured.
-
Heavy-metal or elemental-impurity results where included in the quality programme.
-
Lot number, manufacture date, retest date and storage requirements.
The commonly reported formula is CβββHβββNββOββS, with molecular mass approximately 5,135.78β5,135.86 g/mol. KEGG reports an exact mass near 5,132.7166 Da for the neutral composition. CAS records are inconsistent across catalogues, including 218949-48-5 and 901758-09-6, so the supplier must verify the exact registry designation on the CoA.genome+2
Tesamorelin is normally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.
High purity is essential because a 44-residue peptide may contain deletion sequences, truncated chains, incomplete N-terminal acylation, incomplete amidation, oxidation products and residual synthesis reagents. These impurities can alter retention time, ionisation, solubility, receptor-assay response and concentration calculations.
Principal Laboratory Applications and Research Methodologies
Tesamorelin is suitable for controlled laboratory research involving long-peptide chemistry, GHRH-receptor signalling, analytical method development and in vitro cellular models. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.
Long-peptide RP-HPLC and LC-MS analysis. Tesamorelin can support retention-time assignment, intact-mass confirmation, precursor-ion selection and impurity profiling. Because of its size and N-terminal modification, analysts may need multiple charge-state transitions and orthogonal chromatographic conditions.
Sequence and modification verification. Laboratories may confirm the trans-3-hexenoyl group, C-terminal amide and full-length sequence using high-resolution MS, peptide mapping and suitable chromatographic controls. Mass alone may not distinguish every partial-modification product.
In vitro receptor-signalling models. A verified batch may be incorporated into controlled cell-free or cellular systems examining GHRH-receptor-associated signalling. Studies should include vehicle controls, receptor-negative controls where relevant, concentration verification and independent peptide-integrity checks.
Stability and formulation studies. Researchers may assess temperature, pH, light, oxidation, container material, agitation and freezeβthaw exposure. Long peptides can show adsorption and aggregation, so stability-indicating methods should monitor both concentration and molecular-size distribution.
Using the reported molecular mass of approximately 5,135.8 g/mol, 10 mg corresponds to approximately 1.95 Β΅mol. If the entire quantity were dissolved in 3 mL, the theoretical concentration would be approximately 3.33 mg/mL, or 0.649 mM, before correction for purity, salt form, water content and final volume.
These are formulation calculations only. The actual concentration should be based on the batch CoA and validated laboratory preparation method. Bacteriostatic water should be evaluated for compatibility with LC-MS and in vitro workflows.
Compound Stability, Optimal Storage, and Safe Handling Protocols
Lyophilised tesamorelin should remain sealed, dry and protected from light until required for a validated laboratory procedure. Research guidance commonly recommends storage between β20Β°C and β80Β°C, with the colder condition used for extended archival storage where supported by stability data.siriusmolecules+1
Recommended controls include:
-
Store unopened lyophilised tesamorelin at β20Β°C unless the CoA specifies β80Β°C.
-
Consider β80Β°C for extended archival storage.
-
Keep the vial tightly closed, dry and protected from direct light.
-
Use a moisture-controlled secondary container where appropriate.
-
Allow a sealed vial to reach room temperature before opening to minimise condensation.
-
Use low-binding containers where adsorption could affect recovery.
-
Prepare aliquots if repeated access is expected.
-
Store short-term aqueous solutions at 2β8Β°C only where validated.
-
Use frozen aliquots for longer-term solution storage where supported by stability data.
-
Avoid repeated freezeβthaw cycles and vigorous agitation.
-
Record solvent, pH, concentration, preparation date, operator and storage history.
Tesamorelinβs long sequence and hydrophobic N-terminal modification may influence solubility, adsorption and aggregation. A clear solution should not automatically be assumed to retain full molecular integrity without HPLC or LC-MS confirmation.
Reconstitution should be performed using a validated laboratory procedure. Add the bacteriostatic water gradually, allow the powder to hydrate and mix gently. Avoid vigorous vortexing unless compatibility has been demonstrated. If turbidity, precipitation or unexpected chromatographic changes occur, investigate the material before use.
Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.
Technical Specifications and Molecular Attributes
| Attribute | Specification |
|---|---|
| Product | Tesamorelin, 10 mg, supplied with 3 mL bacteriostatic water |
| Common designation | Tesamorelin; stabilised GHRH(1β44) analogue |
| Sequence | trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL-NHβ |
| Residue count | 44 amino acids |
| Key modifications | N-terminal trans-3-hexenoyl group and C-terminal amide |
| IUPAC name | Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement |
| CAS Registry Number | Verify the exact registry record on the CoA; catalogue records report 218949-48-5 and 901758-09-6 |
| Molecular formula | CβββHβββNββOββS |
| Average molecular mass | Approximately 5,135.8β5,136 g/mol |
| Exact mass | Approximately 5,132.7166 Da |
| Physical state and colour | Lyophilised white to off-white powder |
| Solubility profile | Aqueous reconstitution may be feasible; pH, buffer and container compatibility require validation |
| Typical purity | Proposed target β₯99.0% by RP-HPLC; verify the actual lot-specific result |
| Identity testing | LC-MS, high-resolution MS, RP-HPLC and peptide mapping where appropriate |
| Companion reagent | 3 mL bacteriostatic water |
| Long-term storage | Typically β20Β°C or β80Β°C, sealed and protected from light and moisture |
The sequence, formula and molecular mass should be reconciled against the exact batch documentation. The CAS discrepancy is material and should not be concealed; the CoA should state which registry record corresponds to the supplied structure.pubchem.ncbi.nlm.nih+3
Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents
Pharma Research .eu can position tesamorelin as a documented European long-peptide reagent for analytical chemists, biochemists and laboratory managers. The product file should include a batch-specific CoA, SDS, exact sequence, N-terminal acylation and C-terminal amidation data, purity result, identity information, salt form and storage instructions for both the peptide and bacteriostatic water.
Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.
A quality-focused supplier should be able to discuss:
-
The 44-residue sequence and terminal modifications.
-
The trans-3-hexenoyl group and C-terminal amide.
-
The correct CAS designation for the supplied form.
-
RP-HPLC purity, LC-MS identity and peptide mapping.
-
Residual solvents, moisture and elemental-impurity reporting.
-
Long-peptide adsorption and aggregation controls.
-
Storage, transport and documentation requirements.
Pharma Research .eu should therefore be described as a potential European source for research-grade tesamorelin, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueΒ vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.